Sign in

Emily Blyth

@emilyblyth.bsky.social
18 followers 49 following 14 posts

Associate Professor of Haematology Lead of Immune Effector Cell Service Westmead Hospital and University of Sydney, Australia ISCT ANZ Regional VP

PostsRepliesMedia
Reposted by Emily Blyth
Waggoner Lab @labwaggoner.bsky.social · 22/06/2026
Asymmetric cell division explains why 4-1BBζ CAR-T cells preferentially generate durable memory progeny whereas CD28ζ CAR-T cells skew toward short-lived effector fates @natimmunol.nature.com @i3h-upenn.bsky.social www.nature.com/articles/s41... www.nature.com/articles/s41...
083
Reposted by Emily Blyth
ISCT @isctglobal.bsky.social · 23/06/2026
1-month away from ISCT ANZ 2026, and we’re exciting to bring global experts to Melbourne, as they share the latest breakthroughs in cell and gene therapy, regenerative medicine and immunotherapy. Register now: buff.ly/741idfw Learn more: buff.ly/EkzK3P0
011
Reposted by Emily Blyth
ISCT @isctglobal.bsky.social · 23/06/2026
Be in the room with global CGT leaders at ISCT ANZ 2026 and experience sessions covering the translational pathway from discovery science through to clinical translation and manufacturing. Register: www.isctglobal.org/isctanz2026m... Learn more: www.isctglobal.org/isctanz2026m...
021
Emily Blyth @emilyblyth.bsky.social · 06/05/2026
U2 covers at the welcome! We’re certainly in Dublin! #ISCT2026 @isctglobal.bsky.social
020
Emily Blyth @emilyblyth.bsky.social · 06/05/2026
Cost effectiveness improved with: Marsella Qesari - deep understanding of the biology of the product in the first instance, paired with rational release assays that don’t need all complex assays repeated for each batch. Patrick Hanley - kits, cartridges for release assays. #ISCT2026 8/8
010
Emily Blyth @emilyblyth.bsky.social · 06/05/2026
Where is the sweet spot for regulation of cell therapies - how does the good in GMP need to be? Patrick Hanley - real world evidence of safe manufacture of cell therapies should assist in defining this and increasing confidence within regulatory bodies to avoid overly burdensome requirements. 7/n
110
Emily Blyth @emilyblyth.bsky.social · 06/05/2026
#access4kids established to address this: #ISCT2026 6/n innovationdistrict.childrensnational.org/access4kids-...
innovationdistrict.childrensnational.org
Access4Kids: A new model to pay for pediatric cell and gene therapies
(1 min. read)
100
Emily Blyth @emilyblyth.bsky.social · 06/05/2026
Cath Bollard - In rare diseases (eg paediatrics), non-profit models in academic centers that are already doing IND stage manufacturing would need small/moderate scale investment to scale up to BLA stage from current level of activity. @childrensnational.bsky.social 5/n #ISCT2026
100
Emily Blyth @emilyblyth.bsky.social · 06/05/2026
Becky Cap - Closed systems in decentralised environment not yet fully accepted by regulators. There are important differences between complex processes and stem cell processing or blood banking, but many of the processes are similar. 4/n #vitalant #ISCT2026
110
Emily Blyth @emilyblyth.bsky.social · 06/05/2026
Industry, academia, healthcare and regulators need to work together to ensure the goal of effective therapies available to those that need isn’t lost in the process. #ISCT2026 3/n
100
Emily Blyth @emilyblyth.bsky.social · 06/05/2026
What is the right balance of cost (eg arising from regulation) and risk to ensure successful translation of science to good patient outcomes? 2/n #ISCT2026
100
Emily Blyth @emilyblyth.bsky.social · 06/05/2026
Building sustainable business models for CGT - standing room only for these challenging questions. @isctglobal.bsky.social #ISCT2026 1/n
120
Emily Blyth @emilyblyth.bsky.social · 06/05/2026
Insights into optimization of HSC collection for gene therapy in the first roundtable session for the meeting. #ISCT2026
010
Reposted by Emily Blyth
ISCT @isctglobal.bsky.social · 25/10/2025
5 more days until the deadline for the Insta-Your-Cells Photo Challenge! Do you have a cell image you want to share? Enter your photo today to win complimentary registration to ISCT 2026 Dublin Scientific Annual Meeting! buff.ly/seIwkM0 Photo submitted by Ling Liu.
011
Emily Blyth @emilyblyth.bsky.social · 14/02/2025
4. HSCT with cytokine induced killer cells from Melissa Berrien-Elliott
010
Emily Blyth @emilyblyth.bsky.social · 14/02/2025
3. The holy grail of transplant - no GVHD and no relapse Melody King on combo Orca-T and CD19/22 CART @stanfordpress.bsky.social
110
Emily Blyth @emilyblyth.bsky.social · 14/02/2025
2. Marie Bleakey on CD45RA depletion and minor histocompatibility targeting @fredhutch.bsky.social …
110
Emily Blyth @emilyblyth.bsky.social · 14/02/2025
Best session at #Tandem25 Graft engineering to reduce relapse. Bravissima! 1. @simone-minnie.bsky.social - eloquent on graft vs tumour effects @fredhutch.bsky.social …
transplant.no
140